Postnatal growth, neurodevelopment and altered adiposity after preterm birth - From a clinical nutrition perspective

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 8, 2006, Pages 909-917

  Yeung, Melinda ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Hyperinsulinaemia; Insulin resistance; Neurodevelopment; Protein nutrition; Visceral adiposity

Indexed keywords

ANTIDIABETIC AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; DOCOSAHEXAENOIC ACID; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; LEUKOTRIENE; LIPID EMULSION; OMEGA 3 FATTY ACID; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CATCH UP GROWTH; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DYSLIPIDEMIA; GENETIC ASSOCIATION; GENETIC VARIABILITY; GESTATION PERIOD; GESTATIONAL AGE; GLUCONEOGENESIS; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMMUNOMODULATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; ISCHEMIC HEART DISEASE; LIPOLYSIS; LOW BIRTH WEIGHT; METABOLIC DISORDER; METABOLIC SYNDROME X; MORBIDITY; NERVE CELL DIFFERENTIATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL SUPPORT; OBESITY; PERINATOLOGY; POSTNATAL GROWTH; PREMATURITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; RISK ASSESSMENT; TRANSGENIC MOUSE;

ADIPOSITY; BRAIN; FETAL GROWTH RETARDATION; HUMANS; INFANT NUTRITION PHYSIOLOGY; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; RECEPTORS, ADRENERGIC, BETA-3;

EID: 33746785917     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250600724507     Document Type: Review

References (63)

1. Ehrenkranz RA, Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999;104:280-9.
2. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001;107:270-3.
3. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1970;3:79-83.
4. Vohr BR, McKinley LT. The challenge pays off: early enhanced nutritional intake for VLBW Small-For-Gestation neonates improves long-term outcome. J Pediatr 2003;142:459-61.
5. Latal-Hajnal B, von Siebenthal K, Kovari H, Bucher HU, Largo RH. Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J Pediatr 2003;143:163-70.
6. Ong KK, Dunger DB. Perinatal growth failure. The road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 2002;16:191-207.
7. Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-80.
8. Singhal A, Fewtrell M, Cole TJ, Lucas A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003;361:1089-97.
9. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997;82:402-6.
10. Woods KA, van Helvoirt M, Ong KKL, Mohn A, Levy J, De Zegher F, et al. The somatotropic axis in short children born small for gestation age: relation to insulin resistance. Pediatr Res 2002;51:76-80.
11. Colagiuri S, Miller JB. The 'carnivore connection' - evolutionary aspects of insulin resistance. Eur J Clin Nutri 2002;56(Suppl 1):S30-5.
12. Khani S, Tayek JA. Cortisol increase gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci 2001;101:739-47.
13. Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man. Clin Nutr 2000;19:29-34.
14. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-55.
15. Rajaram S, Carlson SE, Koo WW, Rangachari A, Kelly DP. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 during the first year in term and preterm infants. Pediatr Res 1995;37:581-5.
16. Radetti G, Bozzola M, Paganini C, Valentini R, Gentili L, Tettoni K, Tato L. GH bioactivity and levels of growth hormone, growth hormone-binding protein, insulin like growth factor I, and insulin like growth factor-binding proteins in premature and full-term newborns during the first month of life. Arch Pediatr Adolesc Med 1997;151:170-5.
17. Dominici FP, Cifone D, Bartke A, Turyn D. Role of hyperinsulinaemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene. J Endocrinol 1998;159:15-25.
18. Dominici FP, Cifone D, Bartke A, Turyn D. Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endocrinol 1999;161:383-92.
19. Balbis A, Bartke A, Turyn D. Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci 1996;59:1363-71.
20. Kalhan S, Parimi P. Glucogeogenesis in the fetus and neonate. Semin Perinatol 2002;24:94-106.
21. Uthaya S, Thomas EL, Hamilton G, Doré CJ, Bell J, Modi N. Altered adiposity after extremely preterm birth. Pediatr Res 2005;57:211-5.
22. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999;48:839-47.
23. Banerji M, Faridi N, Atluri R, Chaiken RC, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:137-44.
24. Bouchard C, Després J-P, Mauriége P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993;14:72-93.
25. 3-adrenergic agonists. Rev Endocr Metab Dis 2001;2:385-93.
26. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenetic role of visceral fat b3-adrenoceptors in obesity. J Clin Invest 1995;95:1109-16.
27. 3-adrenoceptor mRNA in man. J Clin Invest 1993;91:344-9.
28. Nedergaard J, Cannon B. Brown adipose tissue: development and function. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: Saunders; 1992. p. 314-25.
29. Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine LJ, Arner P. Evidence for a functional b3-adrenoceptor in man. Br J Pharmacol 1993;110:929-36.
30. Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P. Demonstration of an in vivo functional β3-adrenoceptor in man. J Clin Invest 1995;95:2239-45.
31. 3-adrenoceptors with low lipolytic and human subcutaneous white adipocytes. J Lipid Res 1996;37:87-97.
32. Prusiner SB, Cannon B, Ching TM, Lindberg O. Oxidative metabolism in cells isolated from brown adipose tissue. 2. Catecholamine regulated respiratory control. Eur J Biochem 1968;7:51.
33. Bukowiecki LJ, Follea N, Lupien J, Paradis A. Metabolic relationships between lipolysis and respiration in rat brown adipocytes. J Biol Chem 1981;256:12840.
34. Hoffstedt J, Wahrenberg H, Thörne A, Lönnqvist F. The metabolic syndrome is related to b3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 1996;39:838-44.
35. Muzzin P, Revelli J-P, Kuhne F, Gocayne JD,McCombie WR, Venter JC, et al. An adipose tissue-specific β-adrenergic receptor: molecular cloning and down-regulation in obesity. J Biol Chem 1991;266:24053-8.
36. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995;333:343-7.
37. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, et al. Genetic variation in the beta 3-adrenoceptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-4.
38. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Group LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-51.
39. Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H. Trp64ARg mutation of beta 3-adrenoceptor gene deteriorates lipolysis induced by beta 3-adrenerceptor agonist in human omental adipocytes. Diabetes 1999;48:117-20.
40. 3-adrenoceptorgene variant. Pediatr Res 2004;55:836-41.
41. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
42. Sartipy P, Loskutoff DJ. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-α. J Biol Chem 2003;278:52298-306.
43. Yoshida S, Inadera H, Ishikawa Y, Shinomiya M, Shirai K, Saito Y. Endocrine disorders and body fat distribution. Int J Obes 1991;15(Suppl 2):37-40.
44. De Simone M, Verrotti A, Iughetti L, Palumbo M, Farello G, Di Cesare E, et al. Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin levels in massively obsess adolescent girls. J Endocrinol Invest 2001;24:438-44.
45. Saiki A, Miyashita Y, Wakabayasi K, Kameda N, Shirai K. Reduction of visceral adiposity after operation in a subject with insulinoma. J Atheroscler Thromb 2004;11:209-14.
46. Crescenzo R, Samec S, Antic V, Rohner-Jeanrenaud F, Seydoux J, Monani J-P, et al. A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catchup growth. Diabetes 2003;52:1090-7.
47. Thureen P, Heird WC. Protein and energy requirements of the preterm/low birthweight (LBW) infant. Pediatr Res 2005;57:95R-8R.
48. Kashyap S, Ohira-Kist K, Abildskov K, Towers HM, Sahni R, Ramakrishnan R, et al. Effects of quality of energy intake on growth and metabolic response of enterally fed low-birthweight infants. Pediatr Res 2001;50:390-7.
49. Otto-Buczkowska E, Jarosz-Chrobot P, Benduch M. Importance of glycemic index in glucose homeostasis, lipid metabolism and prevention of obesity [abstract]. Diabetologia Polska 2003;10:406-9.
50. Smith WJ, Underwood LE, Keyes L, Clemmons DR. Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. J Clin Endocrinol Metab 1997;82:3982-8.
51. Simpson HL, Umpleby AM, Russell-Jones DL. Insulin-like growth factor-I and diabetes. A review. Growth Horm IGF Res 1998;8:83-95.
52. Hintz RL. Disorder of growth. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison's principles of internal medicine, 14th ed. New York: McGraw-Hill; 1998. p. 2000.
53. Koch T, Heller AR. Effects of intravenous fish oil on pulmonary integrity and function. Clin Nutr 2002;21(Suppl 2):41-5.
54. Clifton PM, Nestel PJ. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 1998;59:191-4.
55. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Cambell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993;328:238-44.
56. Storlien LH, Pan DA, Kriketos AD, O'Connor J, Caterson ID, Cooney GJ, et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996;31 Suppl:S261-5.
57. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002;227:989-97.
58. Mercuri O, de Tomas E, Itarte H. Prenatal protein depletion and δ-9, δ-6, and δ-5 desaturases in the rat. Lipids 1979;14:822-5.
59. Ozanne Se, Martensz ND, Petry CJ, Hales CN. Maternal low protein diet in rats programs fatty acid desaturase activities in the offspring. Diabetologia 1998;41:1337-42.
60. Chicco A, D'Aessandro ME, Karabatas L, Gutman R, Lombardo YB. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancrease insulin content in normal rats. Ann Nutri Metab 1996;40:61-70.
61. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, et al. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 2003;171:4837-43.
62. Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983;32:117-23.
63. Klein CJ. Nutrient requirements for preterm infant formulate. J Nutr 2002;132:1395S-577S.